Ignite Creation Date:
2025-12-24 @ 12:36 PM
Ignite Modification Date:
2026-01-04 @ 7:05 PM
Study NCT ID:
NCT04284761
Status:
COMPLETED
Last Update Posted:
2024-06-24
First Post:
2020-02-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study to Establish the Feasibility of Biolen for the Local Delivery of Bicalutamide in Patients With Prostate Cancer
Sponsor:
Alessa Therapeutics Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-10-11
Start Date Type:
ACTUAL
Primary Completion Date:
2023-05-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-05-03
Completion Date Type:
ACTUAL
First Submit Date:
2020-02-12
First Submit QC Date:
None
Study First Post Date:
2020-02-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-06-21
Last Update Post Date:
2024-06-24
Last Update Post Date Type:
ACTUAL